LSM12P1

Across TCGA pan-cancer cohorts, LSM12P1 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated LSM12P1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher LSM12P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LSM12P1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and COAD show a favorable association.

KICH, UVM, and PAAD are the cancer types where LSM12P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Quartile	All	0.491	1.000	<.001	74	view →
UVM	DFS	Tertile	III,IV	0.204	0.844	.001	58	view →
PAAD	OS	Median	All	0.295	0.675	<.001	54	view →
BLCA	DFS	Median	All	0.555	0.673	.001	52	view →
CESC	DFS	Median	III,IV	0.564	0.891	.001	52	view →
BRCA	DFS	Quartile	III,IV	0.945	0.779	<.001	42	view →
MESO	OS	Tertile	All	0.254	0.495	.003	37	view →
KIRP	DFS	Tertile	All	0.846	0.949	.005	22	view →
LIHC	DFS	Tertile	All	0.426	0.594	.002	19	view →
COAD	OS	Quartile	II,III,IV	0.977	0.792	.004	16	view →
PRAD	DFS	Quartile	All	0.901	0.681	.001	16	view →
STAD	OS	Quartile	II,III,IV	0.550	0.826	.012	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

LSM12P1–KICH (OS)

Open the KICH breakdown →